If you have been reading about dual agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | 39-residue synthetic peptide |
| Average molecular mass | About 4813.5 Da | Free base form |
| Appearance | White to off-white powder | Solid after lyophilization |
| Solubility class | Freely soluble in water | Also soluble in neutral aqueous buffers |
| Typical storage | At or below -20 °C, desiccated | Protect from light and moisture |
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
Characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity and related-substance profiling, with ultraviolet detection near 214 nanometers. Mass spectrometry confirms molecular mass and reveals modifications such as oxidation or deamidation. Peptide mapping after enzymatic digestion verifies the amino acid sequence, while amino acid analysis supplies compositional data. Circular dichroism and infrared spectroscopy are used to assess secondary structure, particularly the alpha-helical content that influences aggregation behavior in solution.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
== Structure == Bacterial glutathione transferases of all classes are homodimeric enzymes (although heterodimeric isozymes of certain classes are also known). Monomers fold into a two-domain configuration to form the active enzyme structure. These globular proteins have an N-terminal domain that consists of a mixture of alpha-helices and beta strands, while the C-terminal domain is all-helical. The N-terminal domain contains the glutathione-binding site and is a highly conserved region among all GSTs. This domain has a similar composition to thioredoxins, which act as antioxidants by facilitating the reduction of other proteins. In comparison, the region that contains the greatest amount of variability between GST classes is contained in the alpha-2 helix on the C-terminal domain. The predominantly alpha-helical C-terminal domain is involved with the binding of hydrophobic substrates (such as hydrophobic portions of xenobiotics). The specificity of the alpha-2 helix stems from the assortment of amino acids in the domain that interacts with the glycine residue of glutathione.
==== MeSH E05.318.740 – statistics ==== MeSH E05.318.740.100 – actuarial analysis MeSH E05.318.740.150 – analysis of variance MeSH E05.318.740.150.500 – multivariate analysis MeSH E05.318.740.200 – area under curve MeSH E05.318.740.250 – cluster analysis MeSH E05.318.740.250.675 – small-area analysis MeSH E05.318.740.250.700 – space-time clustering MeSH E05.318.740.275 – confidence intervals MeSH E05.318.740.300 – data interpretation, statistical MeSH E05.318.740.350 – discriminant analysis MeSH E05.318.740.400 – factor analysis, statistical MeSH E05.318.740.475 – matched-pair analysis MeSH E05.318.740.500 – models, statistical MeSH E05.318.740.500.475 – likelihood functions MeSH E05.318.740.500.500 – linear models MeSH E05.318.740.500.525 – logistic models MeSH E05.318.740.500.600 – models, economic MeSH E05.318.740.500.600.500 – models, econometric MeSH E05.318.740.500.625 – nomograms MeSH E05.318.740.500.700 – proportional hazards models MeSH E05.318.740.525 – monte carlo method MeSH E05.318.740.600 – probability MeSH E05.318.740.600.200 – Bayes' theorem MeSH E05.318.740.600.400 – likelihood functions MeSH E05.318.740.600.500 – markov chains MeSH E05.318.740.600.600 – odds ratio MeSH E05.318.740.600.700 – proportional hazards models MeSH E05.318.740.600.800 – risk MeSH E05.318.740.600.800.450 – logistic models MeSH E05.318.740.600.800.715 – risk assessment MeSH E05.318.740.600.800.725 – risk factors MeSH E05.318.740.600.900 – uncertainty MeSH E05.318.740.750 – regression analysis MeSH E05.318.740.750.400 – least-squares analysis MeSH E05.318.740.750.425 – linear models MeSH E05.318.740.750.450 – logistic models MeSH E05.318.740.750.725 – proportional hazards models MeSH E05.318.740.872 – sensitivity and specificity MeSH E05.318.740.994 – statistical distributions MeSH E05.318.740.994.250 – binomial distribution MeSH E05.318.740.994.300 – chi-square distribution MeSH E05.318.740.994.500 – normal distribution MeSH E05.318.740.994.750 – poisson distribution MeSH E05.318.740.995 – statistics, nonparametric MeSH E05.318.740.996 – stochastic processes MeSH E05.318.740.996.500 – markov chains MeSH E05.318.740.998 – survival analysis MeSH E05.318.740.998.300 – disease-free survival
pain, redness, or swelling at the injection site; vancomycin flushing syndrome (VFS), previously known as red man syndrome (or "redman syndrome"); thrombophlebitis, which is common when administered through peripheral catheters but not when central venous catheters are used, although central venous catheters are a predisposing factor for upper-extremity deep-vein thrombosis. Damage to the kidneys (nephrotoxicity) and to the hearing (ototoxicity) were side effects of the early, impure versions of vancomycin, and were prominent in clinical trials conducted in the mid-1950s. Later trials using purer forms of vancomycin found nephrotoxicity is an infrequent adverse effect (0.1% to 1% of patients), but this is accentuated in the presence of aminoglycosides. Rare adverse effects associated with intravenous vancomycin (<0.1% of patients) include anaphylaxis, toxic epidermal necrolysis, erythema multiforme, superinfection, thrombocytopenia, neutropenia, leukopenia, tinnitus, dizziness and/or ototoxicity, and DRESS syndrome. Vancomycin can induce platelet-reactive antibodies in the patient, leading to severe thrombocytopenia and bleeding with florid petechial hemorrhages, ecchymoses, and wet purpura. Historically, vancomycin has been considered a nephrotoxic and ototoxic drug, based on numerous case reports in the medical literature following initial approval by the FDA in 1958. But as its use increased with the spread of MRSA beginning in the 1970s, toxicity risks were reassessed.
=== The pro-peptide === The MMPs are initially synthesized as inactive zymogens with a pro-peptide domain that must be removed before the enzyme is active. The pro-peptide domain is part of the "cysteine switch." This contains a conserved cysteine residue that interacts with the zinc in the active site and prevents binding and cleavage of the substrate, keeping the enzyme in an inactive form. In the majority of the MMPs, the cysteine residue is in the conserved sequence PRCGxPD. Some MMPs have a prohormone convertase cleavage site (Furin-like) as part of this domain, which, when cleaved, activates the enzyme. MMP-23A and MMP-23B include a transmembrane segment in this domain.
Sources: en.wikipedia.org
=== Cancer === FcRn may influence the tumor microenvironment by modulating the fate of IgG and immune complexes, which play roles in tumor immunity and immune evasion. FcRn is expressed in certain tumor-associated cells, including tumor-infiltrating macrophages and dendritic cells, where it helps process IgG-bound antigens for presentation and clearance. Altered FcRn expression has been observed in some cancers and may correlate with immune escape or therapeutic resistance, especially in tumors treated with monoclonal antibodies. Moreover, FcRn-mediated recycling can affect the local persistence of therapeutic antibodies in tumor tissues, potentially impacting efficiency.
== Business == George Batten (1854–1918), advertising executive whose firm was part of the merger that created what is now BBDO Clarence Birdseye (1886–1956), inventor, entrepreneur and naturalist who is considered to be the founder of the modern frozen food industry John C. Bogle (1929–2019), founder and CEO of The Vanguard Group, a pioneer in financial investments John J. Cali (1918–2014), real estate developer Israel Crane (1774–1858), merchant J. Clydesdale Cushman (1887–1955), businessman who co-founded the real estate firm Cushman & Wakefield in 1917 Allen B. DuMont (1901–1965), television pioneer and inventor who created the DuMont Television Network Stephen Glasser (1943–2022), American publisher who founded the Legal Times Floyd Hall (born 1935), CEO of Kmart Charles B. Johnson (born 1933), businessman Ken Kurson (born 1968), political consultant, writer and journalist, who was editor-in-chief of The New York Observer between 2013 and 2017 Geraldine Laybourne (born 1947), former TV executive and entrepreneur, co-founder of Nickelodeon and Oxygen cable networks Benjamin Moore (1905–1917), co-founder with his brother Robert of Benjamin Moore & Co, in Brooklyn in 1883; lived in Upper Montclair Guy T. Viskniskki (1876–1949), newspaper editor and news executive who founded the World War I edition of the Stars and Stripes newspaper while serving as a U.S. Army officer in France with the American Expeditionary Force Bernard Wakefield (c. 1883–1967), British-American executive who co-founded the real estate firm Cushman & Wakefield in 1917
On 23 January 2026, Danish prime minister Mette Frederiksen visited Greenland to express support for the people and the island's self-governing government, following comments by US president Donald Trump indicating his willingness to annex the territory. Trump had previously discussed strengthening security in the Arctic region with NATO secretary general Mark Rutte. Both the Danish and Greenlandic governments have affirmed that the island's sovereignty is indisputable, but remain open to discussions on issues such as security and economic development. The crisis eased after Trump withdrew threats of force and new tariffs.
Citicoline (INN), also known as cytidine diphosphate-choline (CDP-choline) or cytidine 5'-diphosphocholine is an intermediate in the generation of phosphatidylcholine from choline, a common biochemical process in cell membranes. Citicoline is naturally occurring in the cells of human and animal tissue, in particular the organs.
In 2010, Ian Read was named CEO. In February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in Sandwich, Kent, which at the time employed 2,400 people. In March 2011, Pfizer acquired King Pharmaceuticals for $3.6 billion in cash. King produced emergency injectables such as the EpiPen. On September 4, 2012, the FDA approved bosutinib (Bosulif) for chronic myelogenous leukemia (CML), a rare type of leukemia and a blood and bone marrow disease that affects primarily older adults. In November 2012, Pfizer received approval from the Food and Drug Administration for Xeljanz, a tofacitinib, for rheumatoid arthritis and ulcerative colitis. The drug had sales of $1.77 billion in 2018, and in January 2019, it was the top drug in the United States for direct-to-consumer advertising, passing adalimumab (Humira). In 2023, the Institute for Clinical and Economic Review (ICER) identified Xeljanz (tofacitinib) as one of five high-expenditure drugs that experienced significant net price increases without new clinical evidence to justify the hikes. Specifically, Xeljanz's wholesale acquisition cost rose by 6%, leading to an additional $72 million in costs to U.S. payers. On February 1, 2013, Zoetis, the Agriculture Division of Pfizer and later Pfizer Animal Health, became a public company via an initial public offering, raising $2.2 billion. Later in 2013, Pfizer completed the corporate spin-off of its remaining stake in Zoetis.
Sources: en.wikipedia.org
=== Target animal safety === In swine, ractopamine is correlated with adverse effects, especially hyperactivity, trembling, and broken limbs, leading to censure by animal rights groups. In a conversation with Boulder Weekly newspaper, Colorado State University Professor of Animal Science Temple Grandin, an expert on animal welfare, described harmful effects of ractopamine on feedlot animals, such as cattle with stiff, sore, and lame limbs, and increased heat stress. In the same column, she also opines that meat from ractopamine-treated animals may be tougher. Ractopamine use is a factor in the incidence of downer pigs, animals that are unable to move or stand.
In Russia, an energy facility in Belgorod Oblast was reportedly set on fire by a drone attack, while two drones crashed into a road in Kaluga Oblast but did not explode. A radio address purportedly made by President Putin was broadcast in Rostov, Belgorod and Voronezh Oblasts, all of which border Ukraine, which claimed the Ukrainian army had entered Russia, adding that martial law had been declared and a nationwide military mobilization had begun while telling residents to evacuate into the interior. The message was broadcast by radio stations in those regions before the Kremlin said it was a hoax caused by a hacking. Belgian officials launched an investigation into the possible use of Belgian-made weapons by pro-Ukrainian Russian partisans in Belgorod, some of whom were seen using FN SCAR assault rifles. The Russian Foreign Ministry summoned the Belgian ambassador in protest over the issue. The EU extended restrictions on imports of Ukrainian agricultural products imposed by Bulgaria, Hungary, Poland, Romania and Slovakia seeking to protect their farmers to 15 September. It also sanctioned nine Russian officials, including a deputy justice minister, judges and a prison official, over the persecution and jailing of Kremlin critic and antiwar activist Vladimir Kara-Murza.
High-concentration H2O2 is referred to as "high-test peroxide" (HTP). It can be used as either a monopropellant (not mixed with fuel) or the oxidizer component of a bipropellant rocket. Use as a monopropellant takes advantage of the decomposition of 70–98% concentration hydrogen peroxide into steam and oxygen. The propellant is pumped into a reaction chamber, where a catalyst, usually a silver or platinum screen, triggers decomposition, producing steam at over 600 °C (1,100 °F), which is expelled through a nozzle, generating thrust. H2O2 monopropellant produces a maximal specific impulse (Isp) of 161 s (1.6 kN·s/kg). Peroxide was the first major monopropellant adopted for use in rocket applications. Hydrazine eventually replaced hydrogen peroxide monopropellant thruster applications primarily because of a 25% increase in the vacuum specific impulse. Hydrazine (toxic) and hydrogen peroxide (less toxic [ACGIH TLV 0.01 and 1 ppm respectively]) are the only two monopropellants (other than cold gases) to have been widely adopted and utilized for propulsion and power applications. The Bell Rocket Belt, reaction control systems for X-1, X-15, Centaur, Mercury, Little Joe, as well as the turbo-pump gas generators for X-1, X-15, Jupiter, Redstone and Viking used hydrogen peroxide as a monopropellant. The RD-107 engines (used from 1957 to present) in the R-7 series of rockets decompose hydrogen peroxide to power the turbopumps. In bipropellant applications, H2O2 is decomposed to oxidize a burning fuel.
Galahad is conceived when Elaine gets the court enchantress Dame Brisen to use magic to trick Lancelot into thinking that he is coming to visit Guinevere. Elaine rapes Lancelot through deception but he instantly flees when he realizes what has happened. Galahad is raised by his aunt in a convent, and when he is eighteen, comes to King Arthur's court and begins the Grail Quest. Only he, Percival, and Bors are virtuous enough to achieve the Grail and restore Pelles.
When sapiens began to expand and spread, he eliminated the other contemporary races [including Neanderthals] just as the white man drove out the Australian aborigines and the North American Indians. In general, the extinction of Neanderthals is ascribed predominantly to competition with modern humans. The success of modern humans over Neanderthals is usually attributed to a higher birth rate and population, facilitated by better long-distance mobility and more complex technologies and subsistence strategies. Some Neanderthal populations may have also been assimilated into modern human populations rather than being ecologically outcompeted. Assimilation had long been hypothesised with supposed hybrid specimens, and was revitalised with the discovery of archaic human DNA in modern humans. Similarly, the Châtelperronian industry of central France and northern Spain may represent a culture of Neanderthals adopting modern human techniques, via acculturation. Other ambiguous transitional cultures include the Italian Uluzzian industry, and the Central European Szeletian industry. Neanderthal extinction has also been ascribed to their low population as well as the resulting mutational meltdown, making them less adaptable to major environmental changes or new diseases introduced by immigrating modern humans. It is unclear if climatic degradation would have severely impacted Neanderthals given how many glacial periods they persisted through in Europe.
Sources: en.wikipedia.org
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.
The C20 fatty diacid promotes tight binding to serum albumin. That binding reduces renal clearance and extends circulation time compared with an unmodified peptide of similar length.
It is not fully established. Studies indicate that both receptors contribute to the observed effects, but the exact split between the two signaling pathways in humans remains an open question.
It separates molecules by hydrophobicity, which is effective for distinguishing an intact peptide from truncated or chemically modified forms. A C18 column with an acidic water-organic mobile phase is a standard configuration.